Top Markets
#1 Black Phoenix Black Phoenix +734.10%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.97%
#3 Biconomy Biconomy +23.39%
#4 TENDIES TENDIES +21.80%
#5 Wrapped STX (Velar) Wrapped STX (Velar) +17.81%
#6 THORChain THORChain +16.98%
#7 MetaDAO MetaDAO +16.83%
#8 THORChain Yield THORChain Yield +12.47%
#9 Moolah Moolah +11.26%
#10 Bless Bless +10.01%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Harbin Pharmaceutical Group Co., Ltd. Harbin Pharmaceutical Group Co., Ltd.

Harbin Pharmaceutical Group Co., Ltd.

600664
Rank in Stocks #4980
Harbin Pharmaceutical Group Co., Ltd. functions as a leading pharmaceutical... Harbin Pharmaceutical Group Co., Ltd. functions as a leading pharmaceutical company, overseeing the complete process from drug discovery and development to manufacturing and global sales. The firm's activities span both domestic Chinese markets and international territories. Its business structure is segmented into seven key areas: Antibiotics, Small-Molecule Drug Formulations, Over-the-Counter (OTC) and Health Products, Modern Chinese Medicine, Biopharmaceutical products, Animal Vaccines, and Pharmaceutical Distribution services. The company's broad product portfolio features a comprehensive selection of penicillin and cephalosporin antibiotics, in addition to vital pharmaceutical intermediates. Its notable offerings include various types of injections, such as Shuang Huanglian and Danshen freeze-dried injections, alongside a wide array of oral medications like roxithromycin dispersible tablets, amoxicillin capsules, and specialized pediatric granules containing paracetamol. The product line also encompasses a diverse range of antibiotics, highlighted by multiple cephalosporin-based injections (e.g., ceftriaxone sodium, cefepime hydrochloride) and penicillin derivatives, alongside extracts from traditional Chinese medicine like Panax ginseng. Furthermore, the group manufactures essential medical protective gear, including disposable surgical and protective masks, as well as isolation and protective gowns. These products are distributed under numerous well-known brands, including Hongyan Yaopin, Guangwei, Renmin Tongtai, and Hayao, among others. The company's headquarters are located in Harbin, China.
Share Price
$1.23
Market Cap
$3.11B
Change (1 day)
4.03%
Change (1 year)
133.40%
Country
CN
Trade Harbin Pharmaceutical Group Co., Ltd. (600664)

Category

Healthcare
Revenue for Harbin Pharmaceutical Group Co., Ltd. (600664)
Revenue in Aug 2026 TTM: 0
According to Harbin Pharmaceutical Group Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Harbin Pharmaceutical Group Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN